Ray Dalio’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-151,560
Closed -$524K 737
2023
Q1
$524K Sell
151,560
-54,223
-26% -$263K ﹤0.01% 642
2022
Q4
$860K Sell
205,783
-7,623
-4% -$28.9K ﹤0.01% 658
2022
Q3
$856K Sell
213,406
-36,117
-14% -$274K ﹤0.01% 721
2022
Q2
$2.82M Sell
249,523
-62,475
-20% -$749K 0.01% 609
2022
Q1
$5.07M Buy
311,998
+126,384
+68% +$3.24M 0.02% 468
2021
Q4
$8.8M Buy
185,614
+39,630
+27% +$2.38M 0.05% 209
2021
Q3
$10.6M Buy
145,984
+112,730
+339% +$8.15M 0.06% 198
2021
Q2
$2.79M Buy
+33,254
New +$2.19M 0.02% 434

Other funds holding NBP

Ray Dalio's NBP Position: Q2 2023 in Review

Ray Dalio sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q2 2023, closing a stake of 151,560 shares — an estimated $524K sold.

Ray Dalio first reported a position in NBP in Q2 2021 and held it in 8 quarters. The position peaked at $10.6M in Q3 2021. 48 funds tracked by Wall St. Rank hold NBP as of Q2 2023.

  • Ray Dalio reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q2 2023 after selling out during the quarter.
  • Ray Dalio sold 151,560 NovaBridge Biosciences American Depositary Shares shares in Q2 2023, an estimated $524K.
  • Ray Dalio first reported a position in NovaBridge Biosciences American Depositary Shares in Q2 2021 and held it in 8 quarters.
  • Ray Dalio's NovaBridge Biosciences American Depositary Shares position peaked at $10.6M in Q3 2021.
  • 48 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q2 2023.

Based on Bridgewater Associates's 13F filing for Q2 2023, filed 11 Aug 2023.